Illumina_Internship_Poster
•
2 likes•182 views
Hochuen Hybseal Evaluation project overview summarized in 3 sentences: The project evaluated Hochuen as a potential second source supplier for Illumina's Hybseal adhesive, which could save $800K annually if qualified, but current Hybseal adhesion does not meet specifications and causes cross-contamination; a fixture was constructed and Hochuen was tested for cross-contamination and dimensions, developing software to analyze data and determine passing beadchips; highlights include reducing Hybseal failures by 50% but bubbles were found in Hochuen's adhesive.
Report
Share
Report
Share
Download to read offline
Recommended
This is only a test
This 3 sentence document provides copyright information for Illumina, Inc. and lists some of their trademarks including Illumina, IlluminaDx, BaseSpace, BeadArray, and Genome Analyzer. It also states that the document is confidential and for internal use only, and provides a date of July 25, 2013.
Sept2016 smallvar illumina_platinumgenomes
This document discusses validating genetic variants using k-mers and pedigree information. It describes checking variants for consistency across family members and founders using k-mer counts. Metrics like the number of genotype errors, number of k-mer errors in founders, normalized k-mer counts, and minimum normalized count are used to validate variants. The document provides an example of validating the reference and alternative alleles for a variant using k-mer matches and identifies inconsistent alternative allele sequences.
Elite Illumina Catalog-2016
The document describes wall decoration services from Elite Illumina, including various design packages with names like Bohemian, Country Home, and Mediterranean. It lists over 1050 paint color shades and decorative coating suggestions for both residential and commercial spaces. Customers can work with Elite Illumina designers and painters to choose colors and get paint application support. Contact information is provided for the company's head office in Dhaka, Bangladesh.
READNA_DiagnosticsWorkshop_AbizarLakdawalla_4
This document introduces the HiSeq 2000 sequencing system from Illumina. It provides 3 key points:
1. The HiSeq 2000 can generate 150-200 gigabases of sequence data per run, significantly more than previous Illumina sequencers, through innovations like a dual-surface flow cell design and four-camera imaging system.
2. It offers a simple, automated workflow for sample preparation, cluster generation, sequencing, and data analysis. Run setup and monitoring can be done through an intuitive touchscreen interface.
3. The HiSeq 2000 provides high-throughput sequencing at an unprecedented cost-effectiveness, allowing thousands of samples to be sequenced per run for applications like bacterial genomes, human exomes, and transcriptomes
Illumina Infinium XT brochure
Production-Scale Genotyping
A new assay and a 96-sample BeadChip enable production-scale genotyping of 100,000 to > 1,000,000 samples/year
Illumina Residences
High Rise Condominium
Illumina Residences Manila
Php 1.7M - 5.8M
Manila, Sta. Mesa
Illumina sheds new light on new living
Urban living can be easy if that home is ideally situated, affordable, accessible, and secure. DMCI Homes' untarnished track record proves that such desirable living environments exist and thrive. Illumina Residences Manila is a high-rise development that's unique, well-designed, and where all advantages converge.
Illumina-General-Overview-Q1-17
This document is a presentation from Illumina about genomics and their company. It discusses how genome sequencing can provide health insights, their progress in clinical adoption and research use, and their mission to improve human health through genomics. It provides details on Illumina's background, products, markets served, and goals to accelerate genomic adoption and establish new businesses in cancer screening and consumer genomics.
Illumina Sequencing
The document describes the steps of Illumina sequencing. Genomic DNA is first fragmented and adapters are ligated to create single-stranded DNA fragments. These fragments are attached to a flow cell and undergo bridge amplification to create clusters of identical DNA fragments. Sequencing occurs through cycles of reversible terminator-based sequencing using fluorescently labeled dNTPs, imaging of the fluorescence, and cleavage of the label and terminator to allow the next cycle. After multiple cycles, the sequenced reads are aligned to the reference genome to determine the original sequence.
Recommended
This is only a test
This 3 sentence document provides copyright information for Illumina, Inc. and lists some of their trademarks including Illumina, IlluminaDx, BaseSpace, BeadArray, and Genome Analyzer. It also states that the document is confidential and for internal use only, and provides a date of July 25, 2013.
Sept2016 smallvar illumina_platinumgenomes
This document discusses validating genetic variants using k-mers and pedigree information. It describes checking variants for consistency across family members and founders using k-mer counts. Metrics like the number of genotype errors, number of k-mer errors in founders, normalized k-mer counts, and minimum normalized count are used to validate variants. The document provides an example of validating the reference and alternative alleles for a variant using k-mer matches and identifies inconsistent alternative allele sequences.
Elite Illumina Catalog-2016
The document describes wall decoration services from Elite Illumina, including various design packages with names like Bohemian, Country Home, and Mediterranean. It lists over 1050 paint color shades and decorative coating suggestions for both residential and commercial spaces. Customers can work with Elite Illumina designers and painters to choose colors and get paint application support. Contact information is provided for the company's head office in Dhaka, Bangladesh.
READNA_DiagnosticsWorkshop_AbizarLakdawalla_4
This document introduces the HiSeq 2000 sequencing system from Illumina. It provides 3 key points:
1. The HiSeq 2000 can generate 150-200 gigabases of sequence data per run, significantly more than previous Illumina sequencers, through innovations like a dual-surface flow cell design and four-camera imaging system.
2. It offers a simple, automated workflow for sample preparation, cluster generation, sequencing, and data analysis. Run setup and monitoring can be done through an intuitive touchscreen interface.
3. The HiSeq 2000 provides high-throughput sequencing at an unprecedented cost-effectiveness, allowing thousands of samples to be sequenced per run for applications like bacterial genomes, human exomes, and transcriptomes
Illumina Infinium XT brochure
Production-Scale Genotyping
A new assay and a 96-sample BeadChip enable production-scale genotyping of 100,000 to > 1,000,000 samples/year
Illumina Residences
High Rise Condominium
Illumina Residences Manila
Php 1.7M - 5.8M
Manila, Sta. Mesa
Illumina sheds new light on new living
Urban living can be easy if that home is ideally situated, affordable, accessible, and secure. DMCI Homes' untarnished track record proves that such desirable living environments exist and thrive. Illumina Residences Manila is a high-rise development that's unique, well-designed, and where all advantages converge.
Illumina-General-Overview-Q1-17
This document is a presentation from Illumina about genomics and their company. It discusses how genome sequencing can provide health insights, their progress in clinical adoption and research use, and their mission to improve human health through genomics. It provides details on Illumina's background, products, markets served, and goals to accelerate genomic adoption and establish new businesses in cancer screening and consumer genomics.
Illumina Sequencing
The document describes the steps of Illumina sequencing. Genomic DNA is first fragmented and adapters are ligated to create single-stranded DNA fragments. These fragments are attached to a flow cell and undergo bridge amplification to create clusters of identical DNA fragments. Sequencing occurs through cycles of reversible terminator-based sequencing using fluorescently labeled dNTPs, imaging of the fluorescence, and cleavage of the label and terminator to allow the next cycle. After multiple cycles, the sequenced reads are aligned to the reference genome to determine the original sequence.
New Generation Sequencing Technologies: an overview
The document provides a history of DNA sequencing technologies. It begins with the discovery of DNA's structure in 1953 and the development of recombinant DNA technology in the 1970s. First generation Sanger sequencing produced short reads over 1,000 years to sequence the human genome. Next generation sequencing (NGS) platforms since 2005 have dramatically reduced costs while increasing throughput. NGS methods like Roche/454 pyrosequencing, Illumina/Solexa sequencing by synthesis, SOLiD ligation sequencing, and single-molecule real-time sequencing by Pacific Biosciences now enable large-scale genome and transcriptome analysis.
Next-Generation Sequencing Commercial Milestones Infographic
Next-generation sequencing (NGS) has revolutionized the way we analyze diseases and commercial outfits such as Illumina, Helicos, QIAGEN and Pacific Biosciences have made significant contributions. In addition, the launch of direct-to-consumer genetic testing solutions has dramatically changed the way consumers access genomics data. Until a few years ago, the cost of sequencing was a major bottleneck. Recent developments have reduced the cost from thousands of dollars to a couple of cents per megabase. When did these changes start? What were the changes in the commercial sector in the last 15 years? This infographic is a timeline of the NGS commercial marketplace.
NGx Sequencing 101-platforms
The field of next-generation sequencing (NGS) has been experiencing explosive growth over the past several years and shows little sign of slowing down. The increasing capabilities and dramatically lowered costs have expanded NGS's reach beyond that of the human genome into nearly every corner of biological research. An overview of the platforms on the market today, including an assessment of their relative strengths and weaknesses, will be presented. The presentation will conclude with a peek into where the technology is going and what will be available in the future.
Illumina GAIIx for high throughput sequencing
1. The document discusses next-generation sequencing (NGS) platforms and focuses on the Illumina Genome Analyzer IIx.
2. The Illumina GAIIx allows for high throughput sequencing through bridge-PCR amplification on a solid surface and sequencing by synthesis using reversible terminators.
3. The document provides information on the applications, sequencing chemistry, advantages, and limitations of the Illumina GAIIx platform for NGS.
Introduction to next generation sequencing
This document provides an introduction to next generation sequencing (NGS) technologies. It begins with an outline of topics to be covered, including the evolution of NGS technologies, their descriptions and comparisons, bioinformatics challenges of NGS data analysis, and some aspects of NGS data analysis workflows and tools. The document then delves into explanations of specific NGS platforms, their performance characteristics, and the sequencing processes. It discusses the large computational infrastructure and data management needs of NGS, as well as quality control, preprocessing of NGS data, and popular analysis tools and workflows.
More Related Content
Viewers also liked
New Generation Sequencing Technologies: an overview
The document provides a history of DNA sequencing technologies. It begins with the discovery of DNA's structure in 1953 and the development of recombinant DNA technology in the 1970s. First generation Sanger sequencing produced short reads over 1,000 years to sequence the human genome. Next generation sequencing (NGS) platforms since 2005 have dramatically reduced costs while increasing throughput. NGS methods like Roche/454 pyrosequencing, Illumina/Solexa sequencing by synthesis, SOLiD ligation sequencing, and single-molecule real-time sequencing by Pacific Biosciences now enable large-scale genome and transcriptome analysis.
Next-Generation Sequencing Commercial Milestones Infographic
Next-generation sequencing (NGS) has revolutionized the way we analyze diseases and commercial outfits such as Illumina, Helicos, QIAGEN and Pacific Biosciences have made significant contributions. In addition, the launch of direct-to-consumer genetic testing solutions has dramatically changed the way consumers access genomics data. Until a few years ago, the cost of sequencing was a major bottleneck. Recent developments have reduced the cost from thousands of dollars to a couple of cents per megabase. When did these changes start? What were the changes in the commercial sector in the last 15 years? This infographic is a timeline of the NGS commercial marketplace.
NGx Sequencing 101-platforms
The field of next-generation sequencing (NGS) has been experiencing explosive growth over the past several years and shows little sign of slowing down. The increasing capabilities and dramatically lowered costs have expanded NGS's reach beyond that of the human genome into nearly every corner of biological research. An overview of the platforms on the market today, including an assessment of their relative strengths and weaknesses, will be presented. The presentation will conclude with a peek into where the technology is going and what will be available in the future.
Illumina GAIIx for high throughput sequencing
1. The document discusses next-generation sequencing (NGS) platforms and focuses on the Illumina Genome Analyzer IIx.
2. The Illumina GAIIx allows for high throughput sequencing through bridge-PCR amplification on a solid surface and sequencing by synthesis using reversible terminators.
3. The document provides information on the applications, sequencing chemistry, advantages, and limitations of the Illumina GAIIx platform for NGS.
Introduction to next generation sequencing
This document provides an introduction to next generation sequencing (NGS) technologies. It begins with an outline of topics to be covered, including the evolution of NGS technologies, their descriptions and comparisons, bioinformatics challenges of NGS data analysis, and some aspects of NGS data analysis workflows and tools. The document then delves into explanations of specific NGS platforms, their performance characteristics, and the sequencing processes. It discusses the large computational infrastructure and data management needs of NGS, as well as quality control, preprocessing of NGS data, and popular analysis tools and workflows.
Viewers also liked (6)
New Generation Sequencing Technologies: an overview
New Generation Sequencing Technologies: an overview
Next-Generation Sequencing Commercial Milestones Infographic
Next-Generation Sequencing Commercial Milestones Infographic
Illumina_Internship_Poster
- 1. © 2013 Illumina, Inc. All rights reserved. Illumina, IlluminaDx, BaseSpace, BeadArray, BeadXpress, cBot, CSPro, DASL, DesignStudio, Eco, GAIIx, Genetic Energy, Genome Analyzer, GenomeStudio, GoldenGate, HiScan, HiSeq, Infinium, iSelect, MiSeq, Nextera, NuPCR, SeqMonitor, Solexa, TruSeq, TruSight, VeraCode, the pumpkin orange color, and the Genetic Energy streaming bases design are trademarks or registered trademarks of Illumina, Inc. All other brands and names contained herein are the property of their respective owners. Diana Carolina Muñoz Test Engineering Intern Hochuen Hybseal Evaluation Overview of Project Evaluated the feasibility of Hochuen becoming qualified as a second source supplier Projected $800K in potential savings annually if Hochuen is qualified. Hochuen’s Hybseal adhesion is not up to required specifications and is the cause for continual cross-contamination within the beadarrays.Concern: Big Thanks to Arjun Sudarsan, Neha Kubal, Darryl Donovan, Carlos Lopez, Trish Bowes, the Dragonfish team, and for this experience! Constructed a fixture to conduct a pressure force experiment on SD manufacturing. Tested Hochuen for cross-contamination and physical dimension verification. Developed software to extract intensity data from typhoon imager to determine which Dragonfish beadchips passed or failed cross-contamination. Project Highlights: Hochuen has decreased their Dragonfish Hybseal cross-contamination failures by 50% Pressure Force Fixture Bubbles found in Hochuen’s Hybseal Adhesive: Hochuen VS. GBLDraft No Draft